This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Canine Neuregulin 1 (NRG1), C-His
Product Overview
BioVenic's Recombinant Canine Neuregulin 1 (NRG1), C-His is a recombinant protein expressed from HEK293 Cells. Its predicted molecular weight is 25.5 kDa. The purity is>90% (SDS-PAGE). The endotoxin level is <1 EU/μg (LAL).
Specifications
Target Information
Neuregulin 1 (NRG1), initially identified as a 44-kD glycoprotein, interacts with the NEU/ERBB2 receptor tyrosine kinase, enhancing its tyrosine phosphorylation. NRG1 is encoded by the NRG1 gene in dogs and is widely distributed throughout the central and peripheral nervous systems.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.
References
- Zhou, X. et al. Regulation of the NRG1/ErbB4 pathway in the intrinsic cardiac nervous system is a potential treatment for atrial fibrillation. Frontiers in physiology. 2018, 9: 1082.